Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 9243736, 11 pages
https://doi.org/10.1155/2017/9243736
Research Article

Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis

1Department of Anaesthesiology and Intensive Care Medicine, Charité University Berlin, Campus Virchow Klinikum and Campus Charité Mitte, Berlin, Germany
2Department for Orthopedic and Trauma Surgery, DRK Kliniken Berlin Westend, Berlin, Germany
3Departments of Anaesthesiology and Intensive Care, Hospital Klagenfurt, Klagenfurt, Austria
4Department of Anesthesiology, Theodor Bilharz Research Institute, Imbaba 30, Giza, Egypt

Correspondence should be addressed to Shaaban A. Mousa; ed.etirahc@asuom.nabaahs

Received 5 October 2016; Accepted 27 December 2016; Published 20 February 2017

Academic Editor: Mirella Giovarelli

Copyright © 2017 Mohammed A. Al-Madol et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. G. De Isla and J. F. Stoltz, “In vitro inhibition of IL-1β catabolic effects on cartilage. A mechanism involved on diacerein anti-OA properties,” Biorheology, vol. 45, no. 3-4, pp. 433–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S.-Y. Sheu, S.-R. Ho, J.-S. Sun, C.-Y. Chen, and C.-J. Ke, “Arthropod steroid hormone (20-Hydroxyecdysone) suppresses IL-1β-induced catabolic gene expression in cartilage,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. I. B. McInnes and G. Schett, “The pathogenesis of rheumatoid arthritis,” The New England Journal Of Medicine, vol. 365, no. 23, pp. 2205–2219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. W. B. Van Den Berg, “Joint inflammation and cartilage destruction may occur uncoupled,” Springer Seminars in Immunopathology, vol. 20, no. 1-2, pp. 149–164, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. K. R. Gheorgehe, M. Korotkova, A. I. Catrina et al., “Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids,” Arthritis Research and Therapy, vol. 11, no. 3, article no. R83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. D. Levy and C. N. Serhan, “Resolution of acute inflammation in the lung,” Annual Review of Physiology, vol. 76, pp. 467–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Corminboeuf and X. Leroy, “FPR2/ALXR agonists and the resolution of inflammation,” Journal of Medicinal Chemistry, vol. 58, no. 2, pp. 537–559, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Harada, E. Sugiyama, S. Takebe et al., “Cooperative induction of 15-lipoxygenase in rheumatoid synovial cells by IL-4 and proinflammatory cytokines,” Clinical and Experimental Rheumatology, vol. 21, no. 6, pp. 753–758, 2003. View at Google Scholar · View at Scopus
  9. N. Dufton, R. Hannon, V. Brancaleone et al., “Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation,” Journal of Immunology, vol. 184, no. 5, pp. 2611–2619, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Kao, R. Gu, Y. Jia et al., “A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis,” British Journal of Pharmacology, vol. 171, no. 17, pp. 4087–4096, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. J. Murray, “The primary mechanism of the IL-10-regulated anti-inflammatory response is to selectively inhibit transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8686–8691, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. P. Donnelly, H. Dickensheets, and D. S. Finbloom, “The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes,” Journal of Interferon & Cytokine Research, vol. 19, no. 6, pp. 563–573, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. K. W. Moore, R. De Waal Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis & Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Altman, E. Asch, D. Bloch et al., “Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee,” Arthritis and Rheumatism, vol. 29, no. 8, pp. 1039–1052, 1986. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Weil, O. Zolk, J. Griepentrog, U. Wenzel, W. H. Zimmermann, and T. Eschenhagen, “Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction,” Cardiovascular Research, vol. 69, no. 2, pp. 412–422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. L. E. Miller, H.-P. Jüsten, J. Schölmerich, and R. H. Straub, “The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages,” The FASEB Journal, vol. 14, no. 13, pp. 2097–2107, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Bresnihan, G. Cunnane, P. Youssef, G. Yanni, O. Fitzgerald, and D. Mulherin, “Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis,” British Journal of Rheumatology, vol. 37, no. 6, pp. 636–642, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Mousa, R. H. Straub, M. Schäfer, and C. Stein, “β-Endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 7, pp. 871–879, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shaqura, X. Li, M. A. Al-Madol et al., “Acute mechanical sensitization of peripheral nociceptors by aldosterone through non-genomic activation of membrane bound mineralocorticoid receptors in naive rats,” Neuropharmacology, vol. 107, pp. 251–261, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. P. M. Graabaek, “Characteristics of the two types of synoviocytes in rat synovial membrane. An ultrastructural study,” Laboratory Investigation, vol. 50, no. 6, pp. 690–702, 1984. View at Google Scholar · View at Scopus
  22. T. Iwanaga, M. Shikichi, H. Kitamura, H. Yanase, and K. Nozawa-Inoue, “Morphology and functional roles of synoviocytes in the joint,” Archives of Histology and Cytology, vol. 63, no. 1, pp. 17–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Q. Chu, M. Field, M. Feldmann, and R. N. Maini, “Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis,” Arthritis & Rheumatism, vol. 34, no. 9, pp. 1125–1132, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Y. Park and M. H. Pillinger, “Interleukin-6 in the pathogenesis of rheumatoid arthritis,” Bulletin of the NYU Hospital for Joint Diseases, vol. 65, no. 1, pp. S4–S10, 2007. View at Google Scholar · View at Scopus
  25. G. Trinchieri, “Interleukin-10 production by effector T cells: Th1 cells show self control,” Journal of Experimental Medicine, vol. 204, no. 2, pp. 239–243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. F. Fiorentino, A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra, “IL-10 inhibits cytokine production by activated macrophages,” The Journal of Immunology, vol. 147, no. 11, pp. 3815–3822, 1991. View at Google Scholar · View at Scopus
  27. M. A. Cassatella, L. Meda, S. Gasperini, F. Calzetti, and S. Bonora, “Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation,” Journal of Experimental Medicine, vol. 179, no. 5, pp. 1695–1699, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. E. A. Vermeij, M. G. A. Broeren, M. B. Bennink et al., “Disease-regulated local IL-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis,” Annals of the Rheumatic Diseases, vol. 74, no. 11, pp. 2084–2091, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Roybal, M. Endo, A. Radu, P. W. Zoltick, and A. W. Flake, “Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model,” Gene Therapy, vol. 18, no. 7, pp. 719–726, 2011. View at Publisher · View at Google Scholar · View at Scopus